DK1221969T3 - Aktivering af antigen-specifikke T-celler med virus/antigen-behandlede dendritiske celler - Google Patents

Aktivering af antigen-specifikke T-celler med virus/antigen-behandlede dendritiske celler

Info

Publication number: DK1221969T3
Authority: DK; Denmark
Prior art keywords: antigen; cells; activation; specific; virus
Prior art date: 1999-10-13

Application number

DK00969488.6T

Other languages

English (en)

Inventor

Thorsten Dr Ahlert

Original Assignee

Thorsten Dr Ahlert

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-10-13

Filing date

2000-10-11

Publication date

2010-08-02

2000-10-11 Application filed by Thorsten Dr Ahlert filed Critical Thorsten Dr Ahlert

2010-08-02 Application granted granted Critical

2010-08-02 Publication of DK1221969T3 publication Critical patent/DK1221969T3/da

Links

210000001744 T-lymphocyte Anatomy 0.000 title abstract 4
239000000427 antigen Substances 0.000 title abstract 4
102000036639 antigens Human genes 0.000 title abstract 4
108091007433 antigens Proteins 0.000 title abstract 4
210000004443 dendritic cell Anatomy 0.000 title abstract 3
241000700605 Viruses Species 0.000 title abstract 2
230000004913 activation Effects 0.000 title abstract 2
229960005486 vaccine Drugs 0.000 abstract 3
239000000203 mixture Substances 0.000 abstract 2
230000028993 immune response Effects 0.000 abstract 1
238000000338 in vitro Methods 0.000 abstract 1
238000001727 in vivo Methods 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/10—Cellular immunotherapy characterised by the cell type used
- A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/10—Cellular immunotherapy characterised by the cell type used
- A61K40/19—Dendritic cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
- A61K40/24—Antigen-presenting cells [APC]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/30—Cellular immunotherapy characterised by the recombinant expression of specific molecules in the cells of the immune system
- A61K40/34—Antigenic peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
- A61K40/41—Vertebrate antigens
- A61K40/42—Cancer antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
- A61K2239/31—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterized by the route of administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
- A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterised by the cancer treated
- A61K2239/49—Breast

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical & Material Sciences (AREA)
Immunology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Virology (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

DK00969488.6T 1999-10-13 2000-10-11 Aktivering af antigen-specifikke T-celler med virus/antigen-behandlede dendritiske celler DK1221969T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP99119980A EP1092439A1 (en)	1999-10-13	1999-10-13	Activation of antigen-specific T cells by virus/antigen-treated dendritic cells
PCT/EP2000/010019 WO2001026680A2 (en)	1999-10-13	2000-10-11	Activation of antigen-specific t cells by virus/antigen-treated dendritic cells

Publications (1)

Publication Number	Publication Date
DK1221969T3 true DK1221969T3 (da)	2010-08-02

Family

ID=8239146

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK00969488.6T DK1221969T3 (da)	1999-10-13	2000-10-11	Aktivering af antigen-specifikke T-celler med virus/antigen-behandlede dendritiske celler

Country Status (10)

Country	Link
US (1)	US20090060946A1 (da)
EP (2)	EP1092439A1 (da)
JP (1)	JP2003511419A (da)
AT (1)	ATE464064T1 (da)
AU (1)	AU782196B2 (da)
CA (1)	CA2387063A1 (da)
DE (1)	DE60044198D1 (da)
DK (1)	DK1221969T3 (da)
ES (1)	ES2343673T3 (da)
WO (1)	WO2001026680A2 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1092439A1 (en) *	1999-10-13	2001-04-18	Thorsten Dr. Ahlert	Activation of antigen-specific T cells by virus/antigen-treated dendritic cells
CN111655280B (zh) *	2017-09-01	2025-01-14	达纳-法伯癌症研究所股份有限公司	用于治疗癌症的bcma和taci抗原特异的免疫原性肽
US12448429B2 (en)	2019-03-06	2025-10-21	Dana-Farber Cancer Institute, Inc.	T cell receptors specific to b-cell maturation antigen for treatment of cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3806565A1 (de) *	1988-03-01	1989-09-14	Deutsches Krebsforsch	Virusmodifizierte tumorvakzinen fuer die immuntherapie von tumormetastasen
KR960701208A (ko) *	1993-03-16	1996-02-24	엔 엔 데이비스	바이러스 단백질에 의해 면역 반응을 자극하는 방법(stimulation of immune response by viral protein)
DE4407538C1 (de) *	1994-03-07	1995-02-23	Deutsches Krebsforsch	Bindungsreagens für Zell-Oberflächenprotein und Effektorzelle
EP1092439A1 (en) *	1999-10-13	2001-04-18	Thorsten Dr. Ahlert	Activation of antigen-specific T cells by virus/antigen-treated dendritic cells

1999
- 1999-10-13 EP EP99119980A patent/EP1092439A1/en not_active Withdrawn
2000
- 2000-10-11 WO PCT/EP2000/010019 patent/WO2001026680A2/en not_active Ceased
- 2000-10-11 EP EP00969488A patent/EP1221969B1/en not_active Expired - Lifetime
- 2000-10-11 ES ES00969488T patent/ES2343673T3/es not_active Expired - Lifetime
- 2000-10-11 DE DE60044198T patent/DE60044198D1/de not_active Expired - Lifetime
- 2000-10-11 CA CA002387063A patent/CA2387063A1/en not_active Abandoned
- 2000-10-11 AT AT00969488T patent/ATE464064T1/de active
- 2000-10-11 AU AU79184/00A patent/AU782196B2/en not_active Ceased
- 2000-10-11 JP JP2001529741A patent/JP2003511419A/ja active Pending
- 2000-10-11 DK DK00969488.6T patent/DK1221969T3/da active
2008
- 2008-10-21 US US12/288,553 patent/US20090060946A1/en not_active Abandoned

Also Published As

Publication number	Publication date
US20090060946A1 (en)	2009-03-05
DE60044198D1 (de)	2010-05-27
ES2343673T3 (es)	2010-08-06
JP2003511419A (ja)	2003-03-25
EP1221969A2 (en)	2002-07-17
AU782196B2 (en)	2005-07-07
WO2001026680A2 (en)	2001-04-19
ATE464064T1 (de)	2010-04-15
EP1221969B1 (en)	2010-04-14
AU7918400A (en)	2001-04-23
EP1092439A1 (en)	2001-04-18
CA2387063A1 (en)	2001-04-19
WO2001026680A3 (en)	2001-11-08

Publication	Publication Date	Title
ATE276758T1 (de)	2004-10-15	Adjuvans-zusammensetzung, enthaltend saponin und ein immunstimulatorisches oligonukleotid
BR0011448A (pt)	2004-12-14	Imidazoquinolinas substituìdas por amida
MY137619A (en)	2009-02-27	8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
MY129263A (en)	2007-03-30	Vaccine composition
EP1594536A4 (en)	2006-09-06	ADJUVANT INFLUENZA VACCINE
BR0116026A (pt)	2004-12-21	Imidazoquinolinas substituìdas por tioéter
BRPI0414381A (pt)	2006-11-21	composição de adjuvante, composição ou composições imunogênica(s), composição de vacina, processo para a fabricação de uma composição imunogênica, composição ou composições farmacêutica(s), kit, métodos para tratar um paciente que sofre de, ou que é suscetìvel a, um tumor, para incrementar uma resposta imune de um mamìfero a um antìgeno e para suscitar uma resposta imune em m mamìfero contra um estado de doença, usos de uma imidazoquinolina ou derivado da mesma e gm-csf e dos componentes
BR0314373A (pt)	2005-07-19	Produto imunogênico estável para a indução de anticorpos contra uma ou várias proteìnas antigênicas em um indivìduo, composições farmacêutica, imunogênica e de vacina e processo de preparação de um produto imunogênico
FR2827605B1 (fr)	2004-07-16	Nouveaux peptides derives de la proteine g du vrs et leur utilisation dans un vaccin
GB2386072A (en)	2003-09-10	Novel vaccine
CO4650186A1 (es)	1998-09-03	Composicion de vacuna
ATE481088T1 (de)	2010-10-15	Embolisierung unter verwendung von poly-4- hydroxybutyrat-partikeln
TR200001948T2 (tr)	2001-02-21	Mikobakteri vaccaesinden türetilen kompozisyonlar ve bunların kullanımları için metotlar.
MX2010006984A (es)	2010-10-25	Vacunas contra la malaria.
DE60137146D1 (de)	2009-02-05	Fusionszellen und zytokin-zusammensetzungen zur behandlung von krankheiten
BR0015597A (pt)	2002-07-23	Uso de anticorpos como vacinas
DE60044198D1 (de)	2010-05-27	Aktivierung antigen-spezifischer t-zellen mit virus/antigen-behandelten dendritischen zellen
WO2000073432A3 (en)	2001-12-20	Activation of dendritic cells to enhance immunity
DE69922804D1 (de)	2005-01-27	Verwendung von polymeren der hyaluronsäure zur mukosalen freigabe von impfstoffen und adjuvantien
EE200200157A (et)	2003-04-15	Vaktsiin
MY127452A (en)	2006-12-29	Vaccines.
WO2005009397A3 (en)	2005-11-17	Human lymphocyte vaccine adjuvant
TW200509964A (en)	2005-03-16	VP1 of foot-and-mouth disease virus
WO2004058807A3 (en)	2004-09-30	Mhc class i restricted t-cell stimulating peptides from hepatitis b virus
WO2005077048A3 (en)	2006-08-10	Immune modulation by regulating expression of the “minor” gene in immune dendritic cells